ABC
ACAD icon

Associated Banc-Corp’s Acadia Pharmaceuticals ACAD Stock Holding History

Associated Banc-Corp’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51
Closed -$2K – 986
2020
Q2 		$2K Hold
51
– – ﹤0.01% 590
2020
Q1 		$2K Buy
+51
New +$2.1K ﹤0.01% 506

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Associated Banc-Corp's ACAD Position: Q3 2020 in Review

Associated Banc-Corp sold out of Acadia Pharmaceuticals (ACAD) in Q3 2020, closing a stake of 51 shares — an estimated $2K sold.

Associated Banc-Corp first reported a position in ACAD in Q1 2020 and held it in 2 quarters. The position peaked at $2K in Q2 2020. 267 funds tracked by Wall St. Rank hold ACAD as of Q3 2020.

  • Associated Banc-Corp reported no remaining Acadia Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Associated Banc-Corp sold 51 Acadia Pharmaceuticals shares in Q3 2020, an estimated $2K.
  • Associated Banc-Corp first reported a position in Acadia Pharmaceuticals in Q1 2020 and held it in 2 quarters.
  • Associated Banc-Corp's Acadia Pharmaceuticals position peaked at $2K in Q2 2020.
  • 267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2020.

Based on Associated Banc-Corp's 13F filing for Q3 2020, filed 12 Nov 2020.